Acthar Gel — CareFirst (Caremark)
acute exacerbations of multiple sclerosis
Initial criteria
- Member has had an inadequate response to a trial of IV methylprednisolone for the current exacerbation
Reauthorization criteria
- All requirements in initial coverage criteria are met
Approval duration
3 weeks